Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of activating CD32b/c comprising administering an antibody that binds BDCA-2 (CD303)

Methods of activating CD32b/c comprising administering an antibody that binds BDCA-2 (CD303)

US Patent 11634495 · Granted Apr 25, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LDLR negative packaging cell line for the production of VSV-G pseudotyped retrov2025
Method for producing a detent pawl2025
Chimeric antigen receptor specific for tumor cells2024
Chimeric antigen receptor specific for BDCA2 antigen2023
Chimeric antigen receptor specific for BDCA2 antigen2023
Chimeric antigen receptor specific for tumor cells2020
Ligating BDCA-2 protein with BDCA-2 specific antibody for detecting or modulatin2019
Method for the reduction and modulation of noise of an electric motor2018
Humanized antibody or fragment thereof specific for CD45R02017
Steering column for a motor vehicle2015
Component with inner and outer teeth and method for manufacturing the component2014
Roll forming method for producing longitudinally toothed profiled bodies in pot-2013